Corpus Intelligence IC Memo — THCC TWIN CITIES COMMUNITY HOSPITAL 2026-04-26 11:20 UTC
IC Memo — THCC TWIN CITIES COMMUNITY HOSPITAL
Investment Committee Memorandum | CA | 122 beds | Grade C | EBITDA uplift $9.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THCC TWIN CITIES COMMUNITY HOSPITAL

CCN 050633 | SAN LUIS OBISPO, CA | 122 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

THCC TWIN CITIES COMMUNITY HOSPITAL is a 122-bed suburban community hospital in SAN LUIS OBISPO, CA with $125.9M in net patient revenue and a 7.4% operating margin. The hospital serves a payer mix of 46.4% Medicare, 7.4% Medicaid, and 46.2% commercial.

Thesis: Turnaround. Our ML models identify $9.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.4% to 14.8% (+736bps).

Net Revenue HCRIS$125.9M
Current EBITDA COMPUTED$9.4M
Operating Margin COMPUTED7.4%
Occupancy HCRIS44.6%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS11.0%
Distress Probability ML49.2%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
191
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 7.4% places it above the state median. Among 191 size-comparable peers (61-244 beds), the median margin is -4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (61-244), prioritizing same-state peers. 191 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THCC TWIN CITIES COMMUNITY HOS (Target)CA122$125.9M7.4%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
KFH - SOUTH SACRAMENTOCA233$803.9M5.9%
COMMUNITY HOSP. MONTEREY PENINCA227$797.2M9.3%
KFH - MANTECACA213$796.8M15.2%
LAC OLIVE VIEW/UCLA MEDICAL CECA225$754.9M-10.5%
KFH - SAN FRANCISCOCA239$734.9M2.6%
MILLS PENINSULA MEDICAL CENTERCA241$704.7M3.7%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$81K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$81K
Total EBITDA Uplift$9.3M
Current EBITDA$9.4M
+ RCM Uplift+$9.3M
Pro Forma EBITDA$18.6M
Current Margin7.4%
Pro Forma Margin14.8%
WC Released (1x)$4.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.4M$154.5M10.72x60.7%
Base (11x exit)10.0x11.0x$14.4M$174.6M12.12x64.7%
Bull Case9.0x11.0x$13.0M$209.8M16.18x74.5%
Bull (12x exit)9.0x12.0x$13.0M$232.7M17.95x78.1%
Bear Case11.0x10.0x$15.9M$103.4M6.53x45.5%
Bear (11x exit)11.0x11.0x$15.9M$118.9M7.50x49.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 191 hospitals with 61-244 beds
  • Same-state prioritization (n=192)
  • Comp margins: P25=-20.3% / P50=-4.5% / P75=4.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.